|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
26
|
|
pubmed:dateCreated |
1992-6-26
|
|
pubmed:abstractText |
Few studies have evaluated the late effects of adjuvant chemotherapy for breast cancer. Moreover, the relation between the risk of leukemia and the amount of drug given and the interaction of chemotherapy with radiotherapy have not been described in detail.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
25
|
|
pubmed:volume |
326
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1745-51
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:1594016-Aged,
pubmed-meshheading:1594016-Alkylating Agents,
pubmed-meshheading:1594016-Breast Neoplasms,
pubmed-meshheading:1594016-Case-Control Studies,
pubmed-meshheading:1594016-Combined Modality Therapy,
pubmed-meshheading:1594016-Cyclophosphamide,
pubmed-meshheading:1594016-Dose-Response Relationship, Drug,
pubmed-meshheading:1594016-Dose-Response Relationship, Radiation,
pubmed-meshheading:1594016-Female,
pubmed-meshheading:1594016-Humans,
pubmed-meshheading:1594016-Leukemia,
pubmed-meshheading:1594016-Leukemia, Myeloid, Acute,
pubmed-meshheading:1594016-Leukemia, Radiation-Induced,
pubmed-meshheading:1594016-Melphalan,
pubmed-meshheading:1594016-Middle Aged,
pubmed-meshheading:1594016-Myelodysplastic Syndromes,
pubmed-meshheading:1594016-Radiotherapy,
pubmed-meshheading:1594016-Radiotherapy Dosage,
pubmed-meshheading:1594016-Risk
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Risk of leukemia after chemotherapy and radiation treatment for breast cancer.
|
|
pubmed:affiliation |
Radiation Epidemiology Branch, National Cancer Institute, Bethesda, Md. 20892.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
